The Diagnostic Utility of Splenectomy in Idiopathic Splenomegaly.


Journal

World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 13 5 2020
medline: 10 2 2021
entrez: 13 5 2020
Statut: ppublish

Résumé

With increasing frequency, patients with idiopathic splenomegaly are referred to surgeons for splenectomy. We evaluated the diagnostic utility of splenectomy and feasibility of a minimally invasive approach in the face of idiopathic splenomegaly. We retrospectively reviewed 68 patients who underwent splenectomy for idiopathic splenomegaly. The primary endpoint was the rate of definitive diagnosis based on final surgical pathology of the removed spleen. Preoperative workup included a bone marrow biopsy and peripheral blood smear in 93% and 100% of patients, respectively, with none having lymphadenopathy warranting biopsy. Splenectomy provided a definitive diagnosis for 44 (64.7%) patients. Of these, 34 (50%) patients had an underlying malignancy, of which more than half were splenic marginal zone lymphoma. There were 33 (48.5%) laparoscopic, 23 (33.8%) open, 10 (14.7%) laparoscopic converted to open, and two (2.9%) laparoscopic hand-assist cases. Conversion to open was due to splenic size [median craniocaudal length 21.8 cm (cm)] in eight and staple line bleeding at the splenic hilum in two patients. Overall, the laparoscopic approach was completed in patients with a smaller splenic size compared to open (median craniocaudal length 15.2 vs. 26.0 cm, p < 0.0001). The open group had one (1.5%) intra-operative mortality due to uncontrollable hemorrhage. Thirty-day complication rates were similar for laparoscopic and open approaches (p = 0.10). Splenectomy is an effective diagnostic modality in determining a pathologic cause for splenomegaly in this patient population. Laparoscopic splenectomy can be performed safely in appropriate cases with craniocaudal splenic size having the largest influence on surgical approach.

Identifiants

pubmed: 32394013
doi: 10.1007/s00268-020-05566-3
pii: 10.1007/s00268-020-05566-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2959-2964

Commentaires et corrections

Type : CommentIn

Références

Dacie JV, Brian MC, Harrison CV et al (1969) Non-tropical idiopathic splenomegaly (primary hypersplenism): a review of 10 cases and their relationship to malignant lymphomas. Br J Haematol 17(4):317–333
pubmed: 5394584 doi: 10.1111/j.1365-2141.1969.tb01378.x
Rodeghiero F (2018) A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP. Br J Haematol 181(2):183–195
pubmed: 29479668 doi: 10.1111/bjh.15090
Chaturvedi S, Arnold DM, McCrae KR (2018) Splenectomy for immune thrombocytopenia: down but not out. Blood 131(11):1172–1182
pubmed: 29295846 pmcid: 5855018 doi: 10.1182/blood-2017-09-742353
Barcellini W, Fattizzo B, Zaninoni A (2019) Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives. J Blood Med 10:265–278
pubmed: 31496855 pmcid: 6690850 doi: 10.2147/JBM.S190327
Santos FP, Tam CS, Kantarjian H et al (2014) Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications, and impact on survival and transformation. Leuk Lymphoma 55(1):121–127
pubmed: 23573823 doi: 10.3109/10428194.2013.794269
Fallah J, Olszewski AJ (2019) Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base. Hematology 24(1):378–386
pubmed: 30885066 doi: 10.1080/16078454.2019.1591570
Hangge P, Sheaffer W, Neville M et al (2019) The diagnostic value of splenectomy in patients without a preoperative diagnosis. Am J Surg 217(1):78–82
pubmed: 29880389 doi: 10.1016/j.amjsurg.2018.05.020
Pottakkat B, Kashyap R, Kumar A et al (2006) Redefining the role of splenectomy in patients with idiopathic splenomegaly. ANZ J Surg 76(8):679–682
pubmed: 16916382 doi: 10.1111/j.1445-2197.2006.03828.x
Carr JA, Shurafa M, Velanovich V (2002) Surgical indications in idiopathic splenomegaly. Arch Surg 137(1):64–68
pubmed: 11772218 doi: 10.1001/archsurg.137.1.64
Cronin CC, Brady MP, Murphy C et al (1994) Splenectomy in patients with undiagnosed splenomegaly. Postgrad Med J 70:288–291
pubmed: 8183775 pmcid: 2397869 doi: 10.1136/pgmj.70.822.288
Osler W (1908) Discussion on splenic enlargements other than leukaemic. Brit Med J 2:1151–1158
doi: 10.1136/bmj.2.2494.1151
O’Reilly RA (1998) Splenomegaly in 2,505 patients at a large university medical center from 1913 to 1955. 1913 to 1962: 2,056 patients. West J Med 169(2):78–87
pubmed: 9735688 pmcid: 1305176
Swaroop J, O’Reilly RA (1999) Splenomegaly at a university hospital compared to a nearby county hospital in 317 patients. Acta Haematol 102(2):83–88
pubmed: 10529511 doi: 10.1159/000040975
Hermann RE, DeHaven KE, Hawk WA (1968) Splenectomy for the diagnosis of splenomegaly. Ann Surg 168(5):896–900
pubmed: 5684193 pmcid: 1387384 doi: 10.1097/00000658-196811000-00017
Isaacson PG, Piris MA, Berger F et al (2008) Splenic B-cell marginal zone lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 185–187
Kalpadakis C, Pangalis GA, Angelopoulou MK et al (2017) Treatment of splenic marginal zone lymphoma. Best Pract Res Clin Haematol 30:139–148
pubmed: 28288709 doi: 10.1016/j.beha.2016.07.004
Thieblemont C, Felman P, Berger F et al (2002) Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. Clin Lymphoma 3(1):41–47
pubmed: 12141954 doi: 10.3816/CLM.2002.n.010
Lenglet J, Traulle C, Mounier N et al (2014) Long-term follow up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment. Leuk Lymphoma 55(8):1854–1860
pubmed: 24206091 doi: 10.3109/10428194.2013.861067
Matharoo GS, Afthinos JN, Gibbs KE (2014) Trends in splenectomy: where does laparoscopy stand? JSLS 18(4):e2014.00239
pubmed: 25587215 pmcid: 4283102 doi: 10.4293/JSLS.2014.00239
Musallam KM, Sfeir PM, Faraj W et al (2013) Postoperative outcomes after laparoscopic splenectomy compared with open splenectomy. Ann Surg 257:1116–1123
pubmed: 23207245 doi: 10.1097/SLA.0b013e318275496a
Terrosu G, Donini A, Baccarani U et al (1998) Laparoscopic versus open splenectomy in the management of splenomegaly: our preliminary experience. Surgery 124:839–843
pubmed: 9823396 doi: 10.1016/S0039-6060(98)70006-6
Grahn S, Alvarez J, Kirkwood K (2006) Trends in laparoscopic splenectomy for massive splenomegaly. Arch Surg 141:755–762
pubmed: 16924082 doi: 10.1001/archsurg.141.8.755
Koshenkov VP, Nemeth ZH, Carter MS (2012) Laparoscopic splenectomy: outcome and efficacy for massive and supramassive spleens. Am J Surg 203:517–522
pubmed: 21924403 doi: 10.1016/j.amjsurg.2011.05.014
Rosen MJ, Brody F, Walsh RM et al (2002) Hand-assisted laparoscopic splenectomy vs conventional laparoscopic splenectomy in cases of splenomegaly. Arch Surg 137:1348–1352
pubmed: 12470097 doi: 10.1001/archsurg.137.12.1348
Kercher KW, Matthews BD, Walsh RM et al (2002) Laparoscopic splenectomy for massive splenomegaly. Am J Surg 183:192–196
pubmed: 11918887 doi: 10.1016/S0002-9610(01)00874-1

Auteurs

Robert Naples (R)

Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk A100, Cleveland, OH, 44195, USA.

Alexander Bertke (A)

Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk A100, Cleveland, OH, 44195, USA.

Aldo Fafaj (A)

Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk A100, Cleveland, OH, 44195, USA.

Samuel J Zolin (SJ)

Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk A100, Cleveland, OH, 44195, USA.

Jonah D Thomas (JD)

Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk A100, Cleveland, OH, 44195, USA.

Clayton Petro (C)

Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk A100, Cleveland, OH, 44195, USA.

David Krpata (D)

Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk A100, Cleveland, OH, 44195, USA.

Ajita S Prabhu (AS)

Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk A100, Cleveland, OH, 44195, USA.

Michael J Rosen (MJ)

Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk A100, Cleveland, OH, 44195, USA.

Steven Rosenblatt (S)

Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk A100, Cleveland, OH, 44195, USA. rosenbs@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH